amphetamine has been researched along with Hallucinations in 50 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 6.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| "Repeated amphetamine (AMPH) exposure in nonhuman primates produces a chronic state of monoamine dysregulation and long-lasting changes in behaviors elicited by acute AMPH (including tracking, grasping "at thin air," manipulating nonapparent stimuli, and hypervigilance) in a manner that bears a marked resemblance to symptoms of both amphetamine psychosis and paranoid schizophrenia." | 3.72 | Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates. ( Castner, SA; Goldman-Rakic, PS, 2003) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 2.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| "The diagnosis of schizophrenia is established principally by the presence of certain psychological symptoms which although subjective can be reliably assessed by standardized interviewing procedures." | 1.26 | Schizophrenia: the nature of the psychological disturbance and its possible neurochemcial basis. ( Crow, TJ, 1979) |
| "NARCOLEPSY IS A DISORDER OF SLEEP CONTROL CHARACTERIZED BY A TETRAD OF SYMPTOMS: sleep attacks, cataplexy, sleep paralysis and hypnagogic hallucinations." | 1.25 | Narcolepsy. ( Foley, A; Murray, TJ, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (86.00) | 18.7374 |
| 1990's | 1 (2.00) | 18.2507 |
| 2000's | 2 (4.00) | 29.6817 |
| 2010's | 3 (6.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Winssen, C | 1 |
| Walters, E | 1 |
| Brakoulias, V | 1 |
| Koh, MT | 1 |
| Ahrens, PS | 1 |
| Gallagher, M | 1 |
| Krishnamurthy, VB | 1 |
| Nallamothu, V | 1 |
| Singareddy, R | 1 |
| Fulde, GW | 1 |
| Forster, SL | 1 |
| Castner, SA | 1 |
| Goldman-Rakic, PS | 1 |
| BARUK, H | 1 |
| JOUBERT, P | 1 |
| POTTIER, C | 1 |
| GEORGELIN, R | 1 |
| DU COUEDIC, H | 1 |
| FISCHER, R | 4 |
| CRUMP, GP | 1 |
| BELL, DS | 1 |
| Yui, K | 1 |
| Ikemoto, S | 1 |
| Ney, PG | 1 |
| Nielsen, EB | 2 |
| Eison, MS | 1 |
| Lyon, M | 2 |
| Iversen, SD | 1 |
| Ellison, G | 1 |
| Crow, TJ | 1 |
| Siomopoulos, V | 1 |
| Satel, SL | 1 |
| Seibyl, JP | 1 |
| Koella, WP | 1 |
| Rockey, MA | 1 |
| Schmidt, CW | 1 |
| Kety, SS | 1 |
| Birkmayer, W | 1 |
| Roth, B | 1 |
| Faber, J | 1 |
| Nevsímalová, S | 1 |
| Tosovský, J | 1 |
| Zarcone, V | 1 |
| Guilleminault, C | 1 |
| Carskadon, M | 1 |
| Dement, WC | 1 |
| Parkes, JD | 1 |
| Fenton, GW | 1 |
| Angrist, B | 1 |
| Sathananthan, G | 1 |
| Wilk, S | 1 |
| Gershon, S | 1 |
| Jones, HB | 1 |
| Bejerot, N | 1 |
| Stanton, MD | 1 |
| Bardoni, A | 1 |
| Aggernaes, A | 1 |
| Hasse, HE | 1 |
| Schönhöfer, PS | 1 |
| Waldmann, H | 1 |
| Murray, TJ | 1 |
| Foley, A | 1 |
| Ellinwood, EH | 2 |
| Sudilovsky, A | 1 |
| Nelson, LM | 1 |
| Snyder, SH | 2 |
| Faillace, L | 2 |
| Hollister, L | 2 |
| Malitz, S | 1 |
| Kanzler, M | 1 |
| Leake, CD | 1 |
| Florio, V | 1 |
| Fuentes, JA | 1 |
| Ziegler, H | 1 |
| Longo, VG | 1 |
| Kass, W | 1 |
| Preiser, G | 1 |
| Jenkins, AH | 1 |
| Scholes, NW | 1 |
| Gutnick, MJ | 1 |
| Prokop, H | 1 |
| DiGiacomo, JN | 1 |
| Cabe, PA | 1 |
| Louria, DB | 1 |
| Smith, DE | 1 |
| Johnson, J | 1 |
| Milner, G | 1 |
6 reviews available for amphetamine and Hallucinations
| Article | Year |
|---|---|
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous Syst | 2015 |
[Stress sensitization induced by stressor and methamphetamine].
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, An | 2004 |
CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action.
Topics: Adrenergic beta-Antagonists; Amphetamine; Animals; Anxiety; Blood-Brain Barrier; Central Nervous Sys | 1985 |
Narcolepsy.
Topics: Adolescent; Adult; Amphetamine; Cataplexy; Child; Diagnosis, Differential; Female; Hallucinations; H | 1973 |
[Somatic complications of drug addiction].
Topics: Adolescent; Adult; Amphetamine; Barbiturates; Female; Hallucinations; Hemiplegia; Hepatitis; Heroin | 1974 |
Effects of drugs on perception in man.
Topics: Afterimage; Amobarbital; Amphetamine; Animals; Antidepressive Agents; Auditory Perception; Barbitura | 1970 |
4 trials available for amphetamine and Hallucinations
| Article | Year |
|---|---|
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topi | 1971 |
Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Dextroamphetamine; Electroencephalography; Eva | 1973 |
2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Topics: Adult; Amphetamine; Blood Pressure; Catecholamines; Chlorpromazine; Clinical Trials as Topic; Euphor | 1967 |
2,5-Dimethoxy-4-methylamphetamine: new hallucinogenic drug.
Topics: Amphetamine; Catecholamines; Euphoria; Hallucinations; Hallucinogens; Humans; Placebos; Psychopharma | 1968 |
40 other studies available for amphetamine and Hallucinations
| Article | Year |
|---|---|
Amphetamine-type stimulant use in acute psychiatric inpatients with delusions.
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Delusions; Hallucinations; Humans; Inp | 2020 |
A greater tendency for representation mediated learning in a ketamine mouse model of schizophrenia.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Delusions; Disease Mo | 2018 |
An interesting case of late age at onset of narcolepsy with cataplexy.
Topics: Amphetamine; Cataplexy; Central Nervous System Stimulants; Dextroamphetamine; Diagnosis, Differentia | 2014 |
Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Female; Hallucinations; Macaca mulatta; Mal | 2003 |
[Therapeutic effects and hazards of amphetamine or psychotonic amines; drug addiction and hallucinatory delusions caused by orthedrine].
Topics: Amines; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Delusions; Hallucinations; Humans; | 1953 |
[Hallucination psychoses due to amphetamine poisoning].
Topics: Amphetamine; Central Nervous System Agents; Hallucinations; Humans; Mental Disorders; Psychotic Diso | 1953 |
Factors involved in drug-produced model psychoses.
Topics: Amphetamine; Amphetamines; Animals; Ergot Alkaloids; Hallucinations; Humans; Mental Disorders; Phene | 1954 |
NARCOLEPSY. A DISCUSSION AND CASE PRESENTATION.
Topics: Amphetamine; Amphetamines; Cataplexy; Diagnosis, Differential; Genetics, Medical; Hallucinations; Hu | 1963 |
COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.
Topics: Amphetamine; Amphetamines; Diagnosis, Differential; Hallucinations; Hallucinogens; Humans; Paranoid | 1965 |
Psychosis in a child, associated with amphetamine administration.
Topics: Amphetamine; Brain Damage, Chronic; Child; Hallucinations; Humans; Male; Movement Disorders; Psychos | 1967 |
Hallucinatory behaviors in primates produced by around-the-clock amphetamine treatment for several days via implanted capsules.
Topics: Amphetamine; Animals; Behavior, Animal; Hallucinations; Hallucinogens; Haplorhini; Humans; Psychoses | 1983 |
Animal model of psychosis: hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication.
Topics: Amphetamine; Animals; Behavior, Animal; Cercopithecus; Hallucinations; Humans; Male; Models, Psychol | 1981 |
Schizophrenia: the nature of the psychological disturbance and its possible neurochemcial basis.
Topics: Amphetamine; Antipsychotic Agents; Brain; Delusions; Diagnosis, Differential; Dopamine; Hallucinatio | 1979 |
Amphetamine psychosis: overview and a hypothesis.
Topics: Affective Symptoms; Amphetamine; Brain; Delusions; Depression, Chemical; Diagnosis, Differential; Do | 1975 |
DSM-III-R criteria for cocaine disorders.
Topics: Amphetamine; Cocaine; Diagnosis, Differential; Hallucinations; Humans; Substance-Related Disorders; | 1991 |
Psychophysics of excitation and tranquilization from a steady-state perspective.
Topics: Amphetamine; Animals; Association; Biological Evolution; Brain; Central Nervous System Stimulants; C | 1968 |
Psychiatric problems of the aged.
Topics: Adjustment Disorders; Aged; Amphetamine; Antidepressive Agents; Antipsychotic Agents; Attitude of He | 1974 |
Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; Disease Susceptibility; Dopamine; Dopamine | 1972 |
The influence of imipramine, dexphenmetrazine and amphetaminsulphate upon the clinical and polygraphic picture of narcolepsy-cataplexy.
Topics: Amphetamine; Cataplexy; Electrocardiography; Electroencephalography; Electromyography; Electrooculog | 1971 |
On the treatment of rapid eye movement narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Depression; Desipramine; Electroencephalograph | 1974 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |
A pharmacological and conceptual reevaluation of hallucinations.
Topics: Amphetamine; Cyclazocine; Dronabinol; Hallucinations; Hallucinogens; Humans; Ketamine; Lysergic Acid | 1974 |
The effects of sensual drugs on behavior: clues to the function of the brain.
Topics: Alcoholic Intoxication; Amphetamine; Barbiturates; Brain; Cannabis; Cocaine; Emotions; Female; Hallu | 1974 |
Drug flashbacks: reported frequency in a military population.
Topics: Adult; Amphetamine; Birth Order; Cannabis; Hallucinations; Humans; Lysergic Acid Diethylamide; Male; | 1972 |
The difference between the experienced reality of hallucinations in young drug abusers and schizophrenic patients.
Topics: Adolescent; Adult; Amphetamine; Auditory Perception; Cannabis; Ethanol; Female; Hallucinations; Hall | 1972 |
[Significance of amphetamine-like drugs in the psychodynamics of drug abuse in juveniles].
Topics: Adult; Amphetamine; Female; Hallucinations; Humans; Male; Methylphenidate; Psychoses, Substance-Indu | 1973 |
Narcolepsy.
Topics: Accidents, Traffic; Adult; Amphetamine; Automobile Driving; Cataplexy; Female; Hallucinations; Human | 1974 |
Behavior and EEG analysis of chronic amphetamine effect.
Topics: Amphetamine; Amygdala; Animals; Arousal; Behavior, Animal; Cats; Disease Models, Animal; Electroence | 1974 |
Hallucinogenic drug reaction-MDA.
Topics: Amphetamine; Animals; Dioxoles; Hallucinations; Hallucinogens; Humans | 1972 |
EEG and behavioral effects in animals of some amphetamine derivatives with hallucinogenic properties.
Topics: Alkaloids; Allyl Compounds; Amino Alcohols; Amphetamine; Animals; Anisoles; Behavior, Animal; Brain; | 1972 |
Inter-relationship of hallucinations and dreams in spontaneously hallucinating patients.
Topics: Adult; Amphetamine; Auditory Perception; Consciousness; Dreams; Electroencephalography; Female; Hall | 1970 |
Relative activity of psychotoxic drugs on the avian optic lobe.
Topics: Amphetamine; Animals; Chickens; Electrophysiology; Female; Hallucinations; Humans; Lysergic Acid Die | 1970 |
Arousal-statebound recall of experience.
Topics: Amnesia; Amphetamine; Arousal; Association; Barbiturates; Consciousness; Dreams; Ethanol; Female; Ha | 1971 |
Amphetamine psychosis. II. Theoretical implications.
Topics: Amphetamine; Cerebral Cortex; Diagnosis, Differential; Epilepsy, Temporal Lobe; Hallucinations; Huma | 1968 |
[Hallucinosis in ephedrine addiction].
Topics: Adult; Amphetamine; Anxiety; Ephedrine; Euphoria; Female; Hallucinations; Humans; Mental Disorders; | 1968 |
Toxic effect of stramonium simulating LSD trip.
Topics: Adolescent; Amphetamine; Atropa belladonna; Body Temperature; Brain Injuries; Datura stramonium; Dia | 1968 |
2,5-Dimethoxy-4-methyl-amphetamine: new hallucinogenic drug.
Topics: Amphetamine; Catecholamines; Hallucinations; Hallucinogens; Humans; Psychopharmacology | 1968 |
Medical complications of pleasure-giving drugs.
Topics: Amphetamine; Barbiturates; Condiments; Drug Synergism; Hallucinations; Hallucinogens; Hepatitis A; H | 1969 |
Speed freaks vs. acid heads. Conflict between drug subcultures.
Topics: Adolescent; Adult; Amphetamine; California; Female; Hallucinations; Humans; Lysergic Acid Diethylami | 1969 |
Psychiatric complications of amphetamine substances.
Topics: Adolescent; Adult; Amitriptyline; Amphetamine; Chlordiazepoxide; Depression; Ephedrine; Female; Hall | 1966 |